{
    "Trade/Device Name(s)": [
        "BD ProbeTec Trichomonas vaginalis (TV) Qx Amplified DNA Assay"
    ],
    "Submitter Information": "BD Diagnostic Systems",
    "510(k) Number": "K130268",
    "Predicate Device Reference 510(k) Number(s)": [
        "K102911"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OUY"
    ],
    "Summary Letter Date": "August 12, 2013",
    "Summary Letter Received Date": "August 13, 2013",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3860"
    ],
    "Regulation Name(s)": [
        "Trichomonas vaginalis nucleic acid amplification test system"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [
        "Trichomonas vaginalis DNA"
    ],
    "Specimen Type(s)": [
        "Endocervical swab",
        "Vaginal swab",
        "Urine"
    ],
    "Specimen Container(s)": [
        "Extraction Tube"
    ],
    "Instrument(s)/Platform(s)": [
        "BD Viper System"
    ],
    "Method(s)/Technology(ies)": [
        "Strand Displacement Amplification (SDA)",
        "Fluorescent probe detection"
    ],
    "Methodologies": [
        "Nucleic acid amplification",
        "Automated extraction"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for BD ProbeTec Trichomonas vaginalis Qx Amplified DNA Assay using SDA technology on BD Viper System for detection of T. vaginalis DNA in female swab and urine specimens",
    "Indications for Use Summary": "Qualitative detection of Trichomonas vaginalis DNA in clinician-collected female endocervical swab specimens, patient-collected vaginal swab specimens (in a clinical setting), and female urine specimens; indicated for use with asymptomatic and symptomatic females to aid in diagnosis of trichomoniasis",
    "fda_folder": "Immunology"
}